Meconium ileus and pancreatic sufficiency with D1152H mutation: A case report and review of the literature.


Journal

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
ISSN: 1873-5010
Titre abrégé: J Cyst Fibros
Pays: Netherlands
ID NLM: 101128966

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 18 04 2022
revised: 19 12 2022
accepted: 04 02 2023
medline: 4 12 2023
pubmed: 10 7 2023
entrez: 9 7 2023
Statut: ppublish

Résumé

Meconium ileus (MI) is one presenting manifestation of Cystic Fibrosis (CF), classically associated with class I-III CF transmembrane conductance regulator (CFTR) mutations and pancreatic insufficiency (PI). D1152H is a class IV mutation that corresponds with a milder CF phenotype and pancreatic sufficiency (PS). We present the case of an infant with G542X/D1152H mutations and MI who required surgical intervention with small bowel resection. The sweat testing was normal, and this child presently remains PS, however at age 5 continues to experience short gut syndrome and failure to thrive. Eight cases were identified in the CF Registry and seven cases in the literature describing patients with D1152H and echogenic bowel (EB) or MI. Our case highlights the importance of CFTR gene sequencing in infants with EB or MI and sweat testing not suggestive of CF. It is our practice to perform full CFTR gene sequencing for infants who present with MI, recognizing protocols for newborn screening across the United States vary. Increased awareness of D1152H association with PS may also well inform both prenatal and postnatal genetic counseling.

Identifiants

pubmed: 37423798
pii: S1569-1993(23)00045-0
doi: 10.1016/j.jcf.2023.02.002
pii:
doi:

Substances chimiques

Cystic Fibrosis Transmembrane Conductance Regulator 126880-72-6

Types de publication

Review Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

1125-1127

Informations de copyright

Copyright © 2023 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest I have no competing interest related to this submission

Auteurs

Emma Lang (E)

Division of Pediatric Pulmonary Medicine, Hassenfeld Children's Hospital, NYU Langone Health, 4th Floor, New York, NY 10016, United States.

Bridget Kiernan (B)

Division of Pediatric Gastroenterology, Hassenfeld Children's Hospital, NYU Langone Health, New York, NY, United States.

Eleanor D Muise (ED)

Division of Pediatric Pulmonary Medicine, Hassenfeld Children's Hospital, NYU Langone Health, 4th Floor, New York, NY 10016, United States.

Robert Giusti (R)

Division of Pediatric Pulmonary Medicine, Hassenfeld Children's Hospital, NYU Langone Health, 4th Floor, New York, NY 10016, United States. Electronic address: Robert.Giusti@nyulangone.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH